Celina Bernabe, DO
Allergy & Immunology · Overland Park, KSNPI 1063518546
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (38.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Pharming Healthcare, Inc. accounts for 66.4% of it on its own, with 39 other manufacturers making up the rest. 2025 is the largest year on record at $20,146, 3.2 times the $6,249 reported in 2019. Among allergy & immunology clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,033 payments — averaging $91.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pharming Healthcare, Inc.$63K
- AstraZeneca$8K
- CSL Behring$6K
- Sanofi$2K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $12K from 34 others
What the payments were for
- Consulting fees$30,43932%
- Speaking & faculty fees$36,84539%
- Travel & lodging$5,5436%
- Food & beverage$21,59123%
- Education$2930%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$94,711 in reported general payments places this provider in the 95th percentile of 33 allergy & immunology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 80 | $612,865 |
| AyvakitAvapritinib | 12 | $465,623 |
| IcatibantIcatibant Acetate | 19 | $185,623 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 26 | $76,150 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 63 | $44,467 |
| Dupixent PenDupilumab | 11 | $41,497 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $38,583 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $28,943 |
| Advair HfaFluticasone Propion/Salmeterol | 20 | $9,655 |
| Arnuity ElliptaFluticasone Furoate | 22 | $6,964 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 47 | $6,697 |
| Epinephrine | 31 | $6,149 |
| SymbicortBudesonide/Formoterol Fumarate | 21 | $5,544 |
| Fluticasone Propionate HfaFluticasone Propionate | 15 | $4,238 |
| Azelastine Hcl | 82 | $3,970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| CSL BehringHizentra | $6,233 | $612,86580 claims |
| Blueprint Medicines CorporationAyvakit | $176 | $465,62312 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $1,360 | $80,374131 claims |
| Grifols USA, LLCGamunex-C | $393 | $76,15026 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $8,238 | $44,12765 claims |
| Hikma Pharmaceuticals USAEpinephrine | $74 | $6,14931 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 33 allergy & immunology providers in Kansas.
Other allergy & immunology in Overland Park
- Henry KanarekOverland Park$143K
- William LaveryOverland Park$25K
- Sara AzzamOverland Park$19K
- Nguyen TranOverland Park$15K
- Cori PasserOverland Park$14K
- Derrick WardOverland Park$6K
- Mark NeustromOverland Park$3K
- James SternerOverland Park$3K
- H LevineOverland Park$3K
- Khaled GirgisOverland Park$636
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.